These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16507114)

  • 1. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.
    Chinoy H; Salway F; Fertig N; Shephard N; Tait BD; Thomson W; Isenberg DA; Oddis CV; Silman AJ; Ollier WE; Cooper RG;
    Arthritis Res Ther; 2006; 8(1):R13. PubMed ID: 16507114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis.
    Arnett FC; Targoff IN; Mimori T; Goldstein R; Warner NB; Reveille JD
    Arthritis Rheum; 1996 Sep; 39(9):1507-18. PubMed ID: 8814062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
    Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.
    Chinoy H; Payne D; Poulton KV; Fertig N; Betteridge Z; Gunawardena H; Davidson JE; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2009 Oct; 48(10):1213-7. PubMed ID: 19690132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population.
    Gao X; Han L; Yuan L; Yang Y; Gou G; Sun H; Lu L; Bao L
    BMC Dermatol; 2014 Jun; 14():9. PubMed ID: 24894810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients.
    Horiki T; Ichikawa Y; Moriuchi J; Hoshina Y; Yamada C; Wakabayashi T; Jackson K; Inoko H
    Tissue Antigens; 2002 Jan; 59(1):25-30. PubMed ID: 11972875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
    Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
    Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA class I and class II alleles with myositis in Japanese patients.
    Furuya T; Hakoda M; Higami K; Ueda H; Tsuchiya N; Tokunaga K; Kamatani N; Kashiwazaki S
    J Rheumatol; 1998 Jun; 25(6):1109-14. PubMed ID: 9632072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
    Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
    J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients.
    Kang EH; Go DJ; Mimori T; Lee SJ; Kwon HM; Park JW; Park MH; Song EY; Ha YJ; Lee EY; Lee YJ; Lee EB; Song YW
    Semin Arthritis Rheum; 2019 Oct; 49(2):283-287. PubMed ID: 30952422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
    O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.
    O'Hanlon TP; Carrick DM; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Dreyfuss J; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2005 Nov; 84(6):338-349. PubMed ID: 16267409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies.
    Hausmanowa-Petrusewicz I; Kowalska-Oledzka E; Miller FW; Jarzabek-Chorzelska M; Targoff IN; Blaszczyk-Kostanecka M; Jablonska S
    Arthritis Rheum; 1997 Jul; 40(7):1257-66. PubMed ID: 9214426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
    Misra AK; Wong NL; Healey TT; Lally EV; Shea BS
    BMC Pulm Med; 2021 Nov; 21(1):370. PubMed ID: 34775966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population.
    Lin JM; Zhang YB; Peng QL; Yang HB; Shi JL; Gu ML; Zhao WM; Wang GC
    HLA; 2017 Dec; 90(6):354-359. PubMed ID: 29106035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.